ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2015

Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD-scid IL-2rg(null) RIP-DTR mice engrafted with human islets.

Chaoxing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.